Belviq: Powerful New Ally in the Battle Against Obesity

The U.S. Food and Drug Administration has approved Belviq, the first new weight-loss drug to win FDA approval in more than a decade. Specifically, the FDA approved the powerful appetite suppressant for adults’ use in combination with strict diet and exercise programs; in clinical trials, Belviq proved safe and effective for patients with body mass indexes (BMI) of 30 or higher. Thirty is the clinical threshold for “morbid obesity.” The FDA also approved Belviq for use by adults with

Read more ...